BAIAP2 and attention deficit-hyperactivity disorder: IRSp53 has also been implicated in ASD (Celestino-Soper et al., 2011; Levy et al., 2011; Toma et al., 2011; Wu et al., 2020), schizophrenia (Fromer et al., 2014; Genovese et al., 2016; Johnson et al., 2016; Purcell et al., 2014) and ADHD (Bonvicini et al., 2016; Liu et al., 2013; Ribasés et al., 2009).